Key result
Permanent pacemaker implantation is associated with ~6.6 minutes of fluoroscopy and low cardiologist radiation exposure.
Why the study?
What are the radiation doses to patients and cardiologists during permanent cardiac pacemaker implantation?
Observational (n=55)
What are the radiation doses to patients and cardiologists during permanent cardiac pacemaker implantation?
Permanent pacemaker implantation involves low radiation exposure to both patients and cardiologists, posing no severe risk when standard protective equipment is used.
Low radiation doses support safety with standard protection in pacemaker implantation; leaves open prospective validation in larger cohorts.
BACKGROUND: The purpose of this study was to determine the patient and cardiologist doses during the implantation of permanent cardiac pacemakers under fluoroscopic control. METHODS: For 55 procedures concerning three different types of pacemakers (DDD, VDD, and VVI), the dose-area product (DAP) meter readings and fluoroscopy times were recorded. From these data, the dose to the operating cardiologist was estimated. RESULTS: The median values of DAP and fluoroscopy time for all the procedures monitored were 11.4 Gycm(2) and 6.6 minute, respectively. For the 22 DDD, 21 VDD, and 12 VVI pacemakers implanted, the respective DAP median values were 14.7, 9.9, and 7.3 Gycm(2) and the respective median fluoroscopy times were 8.4, 5, and 2.9 minutes. The median doses to the hands, chest, eyes, and legs of the cardiologist conducting the manipulations were estimated to 0.21, 0.06, 0.03, and 0.11 mGy, respectively, per procedure. CONCLUSIONS: Compared to the existing literature, the median DAP value of this study is almost identical to the 11.2 Gycm(2) reported from a sample of 627 patients in 17 different x-ray rooms, whereas the fluoroscopy times are within the range of values reported by other authors. Concerning the cardiologist exposure, the estimated values indicate that the implantation of pacemakers is a procedure that does not involve a severe risk, especially if it is taken into account that lead aprons and collars are routinely used.
No takes yet. Share an insight, caveat, or question.
Tsalafoutas et al. (2005) conducted an observational in Permanent cardiac pacemaker implantation (n=55). Permanent cardiac pacemaker implantation under fluoroscopic control was evaluated on Dose-area product (DAP) and fluoroscopy times. Permanent cardiac pacemaker implantation resulted in a median dose-area product of 11.4 Gycm2 and fluoroscopy time of 6.6 minutes, with low estimated radiation doses to the operating cardiologist.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: